by Bruce Brown | March 2, 2021 | Medical
According to the CDC, parents report that 17% of children from ages 3-17 years — approximately 1 in 6 — are diagnosed with a developmental disorder, including autism spectrum disorder (ASD). Children with ASD account for 1 in 54 children overall, but the...
by Bruce Brown | January 12, 2021 | Medical
AI enhancements have made hearing aids more powerful than ever. They can make dynamic adjustments in response to changes in ambient sound, or enhance select frequencies to make conversation more intelligible, such as NuHeara’s IQ Buds Max. Phonak’s Audeo...
![CES 2021: New Non-Contact Sensors Can Track Through Walls [video]](https://i0.wp.com/healthtechinsider.com/wp-content/uploads/Aria-presence-sensing-with-video-600x275-1.jpg?resize=600%2C275&ssl=1)
by Bruce Brown | January 5, 2021 | Enabling Tech
Applications for motion-sensing abound. The ability to track movement of people or objects comes in handy in industrial safety, security, smart buildings, and more. We’ve written about Vayyar’s solid state radio frequency monitors for several years....
![AI-Powered Assistive Glasses for the Blind [video]](https://i0.wp.com/healthtechinsider.com/wp-content/uploads/Envision-AI-Assistive-Glasses-with-Video-600x275-1.jpg?resize=600%2C275&ssl=1)
by Bruce Brown | December 2, 2020 | Health
We wrote about Envision’s smartphone app paired with Google Glass smart eyewear for vision-impaired persons earlier this year in March. At that time, the platform was in the preorder stage and Envision expected to ship the system in August. Then a pandemic...
![Artificial Intelligence Adjusts New Hearing Device [video]](https://i0.wp.com/healthtechinsider.com/wp-content/uploads/Widex-Moment-with-video-600x275-1.jpg?resize=600%2C275&ssl=1)
by Bruce Brown | November 5, 2020 | Health
We write often about advances in over-the-counter hearables suitable for moderate hearing impairments that users can purchase without seeing an audiologist. Most recently we covered Nuheara’s laudable third-generation IQbuds MAX. We’ve also written about...
